Hudson Executive Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CATM
Cardtronics plc Class A Ordinary Shares (UK)
CATM
|
+$43M |
| 2 |
THS
Treehouse Foods
THS
|
+$40.8M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACOR
Acorda Therapeutics
ACOR
|
+$31.1M |
| 2 |
CIT
CIT Group Inc.
CIT
|
+$7.31M |
| 3 |
FCB
FCB Financial Holdings, Inc.
FCB
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 43.32% |
| 2 | Healthcare | 32.74% |
| 3 | Consumer Staples | 10.52% |
| 4 | Financials | 7.99% |
| 5 | Real Estate | 5.43% |
Similar funds
Hudson Executive Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Hudson Executive Capital held 9 positions worth $449M, up 32% from $339M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hudson Executive Capital deployed $62.3M of net new capital in Q2 2018, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Treehouse Foods: 899,400 shares worth $47.2M.
By sector, the portfolio is most concentrated in Industrials at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was CIT Group Inc., an estimated $7.31M trimmed.
- Hudson Executive Capital's largest Q2 2018 buy was Treehouse Foods: 899,400 shares worth $47.2M.
- Hudson Executive Capital added most to Cardtronics plc Class A Ordinary Shares (UK) in Q2 2018, an estimated $43M increase.
- Hudson Executive Capital's biggest Q2 2018 reduction was CIT Group Inc., cutting an estimated $7.31M.
- Hudson Executive Capital fully exited Acorda Therapeutics in Q2 2018, selling an estimated $31.1M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $449M portfolio in Q2 2018.
- Hudson Executive Capital opened 2 new positions and closed 2 in Q2 2018.
- Hudson Executive Capital's portfolio value rose 32% quarter-over-quarter to $449M.
Based on Hudson Executive Capital's 13F filing for Q2 2018, filed 14 Aug 2018.